Evidence map›Paper›PMID 15003975›Full record

ArticleBMJ (Clinical research ed.)2004

Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort.

Ora Paltiel, Yehiel Friedlander, Efrat Tiram, Micha Barchana, Xiaonan Xue, Susan Harlap

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in BMJ (Clinical research ed.), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Molecular mechanisms of preeclampsia.Microvascular research · 2008
    Review
  12. Article
  13. Article
  14. Pre-eclampsia and the risk of cancer.BMJ (Clinical research ed.) · 2004
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Ora PaltielBraun School of Public Health and Community Medicine, Hadassah-Hebrew University, Jerusalem 91120, Israel. ora@vms.huji.ac.il
Yehiel Friedlander
Efrat Tiram
Micha Barchana
Xiaonan Xue
Susan Harlap
Hebrew University of Jerusalem · ILAlbert Einstein College of Medicine · USColumbia University · USHadassah Medical Center · ILIsrael Ministry of Health · IL

Funding

CANCER IN THE JERUSALEM PERINATAL STUDY COHORTR01CA080197 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HARLAP, SUSAN · 1999 to 2005
$3.3M
NCI NIH HHS R01 CA80197
6 · The paper itself

Abstract

objectiveTo compare the incidence of cancer among women with and without a history of pre-eclampsia.

designCohort study.

settingJerusalem perinatal study of women who delivered in three large hospitals in West Jerusalem during 1964-76.

participants37 033 women.

main outcome measuresAge adjusted and multivariable adjusted hazard ratios for cancer incidence for the entire cohort and for women who were primiparous at study entry.

resultsCancer developed in 91 women who had pre-eclampsia and 2204 who did not (hazard ratio 1.27, 95% confidence interval 1.03 to 1.57). The risk of site specific cancers was increased, particularly of the stomach, ovary epithelium, breast, and lung or larynx. The incidence of cancer of the stomach, breast, ovary, kidney, and lung or larynx was increased in primiparous women at study entry who had a history pre-eclampsia.

conclusionsA history of pre-eclampsia is associated with increases in overall risk of cancer and incidence at several sites. This may be explained by environmental and genetic factors common to the development of pre-eclampsia and cancer in this population.

Indexed as

Epidemiologic MethodsFemaleHumansIsraelNeoplasmsPre-EclampsiaPregnancy

Identifiers

PMID15003975
PMCPMC390203
OpenAlexW2100322688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.